Abiopharma

News list

Director SCHEINBERG DAVID A 🟢 acquired 50.0K shares of SELLAS Life Sciences Group, Inc. (SLS) Transaction Date: Jan 07, 2026 | Filing ID: 002509

Full text

News bot Jan. 9, 2026, 9:41 p.m.
🔍 SCHEINBERG DAVID A (Director)

Company: SELLAS Life Sciences Group, Inc. (SLS)

Report Date: 2026-01-07
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 50,000
Detailed Transactions and Holdings:
- Acquired 50,000 shares of Common Stock (Direct)
  Date: 2026-01-07 | Code: A | equity_swap_involved: 0 | shares_owned_after: 73,082.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The Reporting Person received an award of 50,000 restricted stock units on January 7, 2026, which shall vest in full on December 1, 2026, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.